A股收評:深成指、創業板指均跌逾1.3%!減肥藥板塊逆市走高
A股主要指數今日低開低走,午後深成指、創業板指均跌逾1%;截至收盤,滬指跌0.92%報2905點,深證成指跌1.38%,創業板指跌1.66%。超4100股下跌,全天成交7224億元,較前一日縮量599億元。盤面上,禮來預計減肥藥將擺脱供應短缺問題,減肥藥板塊走高,華森製藥升停;國家藥監局同意在北京上海開展優化創新藥臨牀試驗審評審批試點,創新藥板塊走強,睿智醫藥20%升停;COMEX黃金期貨一度突破2500美元/盎司關口,貴金屬板塊拉昇,曉程科技升超7%;豬肉概念、輔助生殖及阿茲海默等板塊升幅居前。另外,半導體板塊全線下挫,AI芯片、汽車芯片及存儲芯片等方向領跌,航宇微、協創數據跌超9%;PCB概念走低,則成電子跌超11%;美國對英偉達啟動反壟斷調查,英偉達概念走弱,東方精工跌超8%;AI手機、CPO概念及消費電子等板塊跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.